May 6, 2008
Roche Targets Diabetes to Replace Cancer Sales, Challenge Lilly (Bloomberg.com)
 |
May 7 (Bloomberg) — Cancer drugs have propelled Roche Holding AG's profit by more than 20 percent a year since 2004. To continue the pace, the Swiss company is racing to break into the fast-expanding, $21 billion-a-year diabetes market.
|
